Intraosseous Infusion Devices

Intraosseous Infusion Devices

Global Intraosseous Infusion Devices Market to Reach US$8.2 Billion by 2030

The global market for Intraosseous Infusion Devices estimated at US$5.4 Billion in the year 2023, is expected to reach US$8.2 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Automatic Technology, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$5.6 Billion by the end of the analysis period. Growth in the Manual Technology segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 5.8% CAGR

The Intraosseous Infusion Devices market in the U.S. is estimated at US$1.5 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 5.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.1% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Intraosseous Infusion Devices Market - Key Trends & Drivers Summarized

What Are Intraosseous Infusion Devices and Why Are They Critical in Emergency Medical Care?

Intraosseous infusion devices are specialized medical tools designed to deliver fluids, medications, and blood products directly into the bone marrow when traditional intravenous (IV) access is not feasible. These devices are critical in emergency medical care, particularly in situations where time is of the essence, such as during trauma, cardiac arrest, or shock, where patients may have collapsed veins or other conditions that make IV access difficult. Intraosseous infusion provides a rapid, reliable, and effective alternative for vascular access, ensuring that lifesaving treatments can be administered quickly. The use of these devices is growing, especially in emergency rooms, intensive care units, and military settings, where immediate vascular access can significantly impact patient outcomes.

How Are Technological Advancements Shaping the Intraosseous Infusion Devices Market?

Technological advancements are playing a significant role in shaping the intraosseous infusion devices market, particularly through innovations in device design, ease of use, and safety features. Modern intraosseous devices are increasingly being designed for automatic or semi-automatic deployment, which reduces the skill level required for insertion and minimizes the risk of complications. These devices now often feature safety mechanisms to prevent needle-stick injuries and to ensure secure placement within the bone marrow. Additionally, advancements in materials and engineering have led to the development of more durable and reliable devices that can withstand the rigors of emergency use. These innovations are making intraosseous infusion more accessible to a broader range of healthcare providers, thereby expanding its use in pre-hospital, hospital, and military environments.

Why Is There an Increasing Demand for Intraosseous Infusion Devices Across Healthcare Settings?

The demand for intraosseous infusion devices is increasing across healthcare settings due to the growing recognition of their effectiveness in critical care situations and the expanding training programs for healthcare professionals. As more healthcare providers, including paramedics, emergency physicians, and military medics, are trained in the use of intraosseous devices, their adoption is becoming more widespread. The devices are particularly valued in settings where rapid access to the circulatory system is essential, such as in emergency rooms and during transport of critically ill patients. Additionally, the increasing prevalence of chronic diseases and conditions that can lead to vascular complications is driving the need for alternative vascular access methods, further boosting demand for intraosseous infusion devices. The adoption of these devices is also supported by updated clinical guidelines and protocols that recommend their use in specific emergency situations, reinforcing their role in modern medical practice.

What Factors Are Driving the Growth in the Intraosseous Infusion Devices Market?

The growth in the intraosseous infusion devices market is driven by several factors closely tied to technological advancements, expanding applications, and the increasing need for rapid vascular access in critical care. One of the primary drivers is the advancement in device design, which has made intraosseous infusion easier to perform, safer, and more reliable. This has led to broader adoption across various healthcare settings, including emergency departments, intensive care units, and pre-hospital care. The rising incidence of trauma, cardiac emergencies, and other conditions requiring immediate vascular access is also fueling market growth, as these devices offer a fast and effective alternative when traditional IV access is challenging. Additionally, the growing focus on improving patient outcomes in emergency situations, along with the increasing availability of training for healthcare professionals, is driving the market forward. As these trends continue to evolve, the intraosseous infusion devices market is expected to experience sustained growth, driven by the need for advanced, reliable, and rapid vascular access solutions in critical care scenarios.

Select Competitors (Total 42 Featured) -
  • Aero Healthcare
  • Becton, Dickinson and Company
  • Biopsybell Srl
  • Cook Medical, Inc.
  • PAVmed, Inc.
  • PerSys Medical
  • Pyng Medical
  • Teleflex, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Intraosseous Infusion Devices – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Demand for Rapid Access in Emergency Medicine Spurs Adoption of Intraosseous Infusion Devices
Advancements in Device Technology Propel Innovation in Intraosseous Infusion
Shift Towards Minimally Invasive Emergency Procedures Expands Market Opportunities
Increasing Adoption of Intraosseous Infusion in Pediatric and Geriatric Patients
Role of Intraosseous Devices in Military and Disaster Medicine
Growing Importance of Immediate Vascular Access in Critical Care
Expansion of Pre-Hospital Care Drives Demand for Portable Intraosseous Devices
Emerging Markets Present New Opportunities for Intraosseous Device Manufacturers
Push for Cost-Effective and Easy-to-Use Infusion Solutions
Role of Intraosseous Devices in Enhancing Survival Rates in Trauma Cases
Integration of Intraosseous Infusion Devices with Advanced Monitoring Systems
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Sternum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Sternum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Sternum by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Distal & Proximal Tibia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Distal & Proximal Tibia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Distal & Proximal Tibia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Distal Femur by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Distal Femur by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Distal Femur by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Calcaneus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Calcaneus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Calcaneus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Head of Humerus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Head of Humerus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Head of Humerus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Automatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Automatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Automatic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Manual by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Manual by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Manual by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for EMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for EMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for EMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 26: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 27: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 29: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 30: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 31: World Recent Past, Current & Future Analysis for Cardiac Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 32: World Historic Review for Cardiac Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 33: World 16-Year Perspective for Cardiac Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 34: World Intraosseous Infusion Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 35: World Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 36: World Historic Review for Intraosseous Infusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: World 16-Year Perspective for Intraosseous Infusion Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 38: USA Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: USA Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: USA 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: USA Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: USA 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
TABLE 44: USA Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: USA Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: USA 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
CANADA
TABLE 47: Canada Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Canada 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Canada 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
TABLE 53: Canada Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Canada Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Canada 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
JAPAN
Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 56: Japan Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Japan 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
TABLE 59: Japan Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Japan Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Japan 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
TABLE 62: Japan Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Japan Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: Japan 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
CHINA
Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 65: China Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: China Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: China 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
TABLE 68: China Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: China Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: China 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
TABLE 71: China Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: China Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: China 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
EUROPE
Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 74: Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Europe 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
TABLE 77: Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Europe 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Europe 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
TABLE 83: Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 84: Europe Historic Review for Intraosseous Infusion Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Europe 16-Year Perspective for Intraosseous Infusion Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
FRANCE
Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 86: France Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: France Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: France 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
TABLE 89: France Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: France Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: France 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
TABLE 92: France Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: France Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: France 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
GERMANY
Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 95: Germany Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Germany Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Germany 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
TABLE 98: Germany Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Germany Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Germany 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
TABLE 101: Germany Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Germany Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Germany 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
ITALY
TABLE 104: Italy Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Italy Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Italy 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
TABLE 107: Italy Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Italy Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Italy 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
TABLE 110: Italy Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: Italy Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: Italy 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
UNITED KINGDOM
Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 113: UK Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: UK Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: UK 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
TABLE 116: UK Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: UK Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: UK 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
TABLE 119: UK Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: UK Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: UK 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Rest of Europe Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Rest of Europe 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Rest of Europe Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Rest of Europe 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Rest of Europe Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Rest of Europe 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: Asia-Pacific Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Asia-Pacific 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Asia-Pacific Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Asia-Pacific 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Asia-Pacific Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Asia-Pacific 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 140: Rest of World Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Rest of World Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Rest of World 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
TABLE 143: Rest of World Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Rest of World Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Rest of World 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
TABLE 146: Rest of World Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Rest of World Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Rest of World 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings